Low-density lipoprotein-dependent and independent effects of statins on prevention of major coronary events: Meta-regression of randomized placebo-controlled trials-Reference-Cited by-同舟云学术

Low-density lipoprotein-dependent and independent effects of statins on prevention of major coronary events: Meta-regression of randomized placebo-controlled trials

Published:2013-10 Issue:5 Volume:168 Page:4850-4853
ISSN:0167-5273
Container-title:International Journal of Cardiology
language:en
Short-container-title:International Journal of Cardiology

Author:

Takagi Hisato,Umemoto Takuya

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference64 articles.

1. Comparative benefits of statins in the primary and secondary prevention of major coronary events and all-cause mortality: a network meta-analysis of placebo-controlled and active-comparator trials;Naci;Eur J Prev Cardiol,2013

2. Relation of different measures of low-density lipoprotein cholesterol to risk of coronary artery disease and death in a meta-regression analysis of large-scale trials of statin therapy;Kizer;Am J Cardiol,2010

3. Effects of pravastatin in patients with serum total cholesterol levels from 5.2 to 7.8mmol/liter (200 to 300mg/dl) plus two additional atherosclerotic risk factors;The Pravastatin Multinational Study Group for Cardiac Risk Patients;Am J Cardiol,1993

4. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels;The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group;N Engl J Med,1998

5. Results of the low-dose (20mg) pravastatin GISSI Prevenzione trial in 4271 patients with recent myocardial infarction: do stopped trials contribute to overall knowledge?;GISSI Prevenzione Investigators (Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico);Ital Heart J,2000

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ebola: Is there a hope from treatment with cardiovascular drugs?;International Journal of Cardiology;2014-12

2. Long-term efficacy and safety of statin treatment beyond six years: A meta-analysis of randomized controlled trials with extended follow-up;Pharmacological Research;2014-03

3. A low-density lipoprotein-dependent effect of atorvastatin upon the systolic blood pressure reduction: Meta-regression analyses of randomized trials;International Journal of Cardiology;2013-12